Silver Book Fact

An estimated 1.75 million Americans currently have age-related macular degeneration (AMD). That number is expected to grow to 2.95 million by 2020. * Note that an additional 7.3 million currently at substantial risk for AMD are not included in these projections.

Friedman D, O'Colmain B, Munoz B, Toma S. Prevalence of Age-Related Macular Degeneration in the United States. Archives of Ophthalmology. 2004; 122(4): 564-72. http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&uid=15078675&cmd=showdetailview&indexed=google

Reference

Title
Prevalence of Age-Related Macular Degeneration in the United States
Publication
Archives of Ophthalmology
Publication Date
2004
Authors
Friedman D, O'Colmain B, Munoz B, Toma S
Volume & Issue
Volume 122, Issue 4
Pages
564-72
URL
Read Full Resource

Categories

  • Cost of Disease
  • Future Human Burden

Related Facts

  • The number of people in the U.S. with visual impairment or blindness is expected to double to more than 8 million by 2050.
     
  • The average direct cost of glaucoma treatment ranges from $623 per year for patients with early-stage glaucoma, to $2,511 per year for end-stage patients. Medication costs make up the largest…  
  • In 2001, an estimated 1.4 million age-related macular degeneration (AMD) patients visited physicians or hospitals for treatment of their disease.  
  • Various studies found between 13% and 24% of age-related macular degeneration (AMD) patients had experienced visual hallucinations.  
  • In 2001, approximately 420,000 diabetic retinopathy patients visited physicians or hospitals for treatment of their disease.